• 1
    Dean BB, Gano AD Jr, Knight K, et al. Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clin Gastroenterol Hepatol 2004; 2: 65664.
  • 2
    Barlow WJ, Orlando RC. The pathogenesis of heartburn in nonerosive reflux disease: a unifying hypothesis. Gastroenterology 2005; 128: 7718.
  • 3
    Smith JL, Opekun AR, Larkai E, et al. Sensitivity of the esophageal mucosa to pH in gastroesophageal reflux disease. Gastroenterology 1989; 96: 6839.
  • 4
    Weusten BLAM, Smout AJPM. Ambulatory monitoring of esophageal pH and pressure. In: CastellDO, RichterJE, eds. The Esophagus. Philadelphia: Lippincott Williams & Wilkins, 2004: 13550.
  • 5
    Martinez SD, Malagon IB, Garewal HS, et al. Non-erosive reflux disease (NERD) – acid reflux and symptom patterns. Aliment Pharmacol Ther 2003; 17: 53745.
  • 6
    Jung B, Steinbach J, Beaumont C, et al. Lack of association between esophageal acid sensitivity detected by prolonged pH monitoring and Bernstein testing. Am J Gastroenterol 2004; 99: 4105.
    Direct Link:
  • 7
    Lenglinger J, Eisler M, Riegler M. NERD and ‘GERD without burn’: no more a miracle. Gastroenterology 2005; 129: 396; author reply 3967.
  • 8
    Fass R, Tougas G. Functional heartburn: the stimulus, the pain, and the brain. Gut 2002; 51: 88592.
  • 9
    Wiener GJ, Richter JE, Copper JB, et al. The Symptom Index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring. Am J Gastroenterol 1988; 83: 35861.
  • 10
    Breumelhof R, Smout AJ. The Symptom Sensitivity Index: a valuable additional parameter in 24-hour esophageal pH recording. Am J Gastroenterol 1991; 86: 1604.
  • 11
    Ghillebert G, Janssens J, Vantrappen G, et al. Ambulatory 24 h intraoesophageal pH and pressure recordings v provocation tests in the diagnosis of chest pain of oesophageal origin. Gut 1990; 31: 73844.
  • 12
    Weusten BL, Roelofs JM, Akkermans LM, et al. The symptom-association probability: an improved method for symptom analysis of 24-hour esophageal pH data. Gastroenterology 1994; 107: 17415.
  • 13
    Lam HG, Breumelhof R, Roelofs JM, et al. What is the optimal time window in symptom analysis of 24-hour esophageal pressure and pH data? Dig Dis Sci 1994; 39: 4029.
  • 14
    Taghavi SA, Ghasedi M, Saberi-Firoozi M, et al. Symptom association probability and symptom sensitivity index: preferable but still suboptimal predictors of response to high dose omeprazole. Gut 2005; 54: 106771.
  • 15
    Watson RG, Tham TC, Johnston BT, et al. Double blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux – the ‘sensitive oesophagus’. Gut 1997; 40: 58790.
  • 16
    Prakash C, Clouse RE. Value of extended recording time with wireless pH monitoring in evaluating gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2005; 3: 32934.
  • 17
    Bredenoord AJ, Weusten BL, Timmer R, et al. Addition of esophageal impedance monitoring to pH monitoring increases the yield of symptom association analysis in patients off PPI therapy. Am J Gastroenterol 2006; 101: 4539.
    Direct Link:
  • 18
    Zerbib F, Roman S, Ropert A, et al. Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy. Am J Gastroenterol 2006; 101: 195663.
    Direct Link:
  • 19
    Mainie I, Tutuian R, Shay S, et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy. A multicentre study using combined ambulatory impedance-pH monitoring. Gut 2006; 55: 1398402.
  • 20
    Mainie I, Tutuian R, Hila A, et al. Symptom type on PPI therapy does not predict reflux identified by MII-pH. Gastroenterology 2006; 130: A630 (abstract).
  • 21
    Wunderlich AW, Murray JA. Temporal correlation between chronic cough and gastroesophageal reflux disease. Dig Dis Sci 2003; 48: 10506.
  • 22
    Sifrim D, Dupont L, Blondeau K, et al. Weakly acidic reflux in patients with chronic unexplained cough during 24 h pressure, pH, and impedance monitoring. Gut 2005; 54: 44954.
  • 23
    Holzer P. Acid-sensitive ion channels in gastrointestinal function. Curr Opin Pharmacol 2003; 3: 61825.
  • 24
    Matthews PJ, Aziz Q, Facer P, et al. Increased capsaicin receptor TRPV1 nerve fibres in the inflamed human oesophagus. Eur J Gastroenterol Hepatol 2004; 16: 897902.
  • 25
    Geppetti P, Trevisani M. Activation and sensitisation of the vanilloid receptor: role in gastrointestinal inflammation and function. Br J Pharmacol 2004; 141: 131320.
  • 26
    Waldmann R, Champigny G, Bassilana F, et al. A proton-gated cation channel involved in acid-sensing. Nature 1997; 386: 1737.
  • 27
    Page AJ, Brierley SM, Martin CM, et al. The ion channel ASIC1 contributes to visceral but not cutaneous mechanoreceptor function. Gastroenterology 2004; 127: 173947.
  • 28
    Waldmann R, Champigny G, Lingueglia E, et al. H(+)-gated cation channels. Ann N Y Acad Sci 1999; 868: 6776.
  • 29
    Siddiqui A, Rodriguez-Stanley S, Zubaidi S, et al. Esophageal visceral sensitivity to bile salts in patients with functional heartburn and in healthy control subjects. Dig Dis Sci 2005; 50: 815.
  • 30
    Vaezi MF, Richter JE. Synergism of acid and duodenogastroesophageal reflux in complicated Barrett’s esophagus. Surgery 1995; 117: 699704.
  • 31
    Page AJ, Martin CM, Blackshaw LA. Vagal mechanoreceptors and chemoreceptors in mouse stomach and esophagus. J Neurophysiol 2002; 87: 2095103.
  • 32
    Weusten BL, Smout AJ. Analysis of 24-h oesophageal pH and pressure recordings. Eur J Gastroenterol Hepatol 1995; 7: 114751.
  • 33
    Weusten BL, Akkermans LM, VanBerge-Henegouwen GP, et al. Symptom perception in gastroesophageal reflux disease is dependent on spatiotemporal reflux characteristics. Gastroenterology 1995; 108: 173944.
  • 34
    Weusten BL, Akkermans LM, VanBerge-Henegouwen GP, et al. Spatiotemporal characteristics of physiological gastroesophageal reflux. Am J Physiol 1994; 266: G35762.
  • 35
    Weusten BL, Akkermans LM, VanBerge-Henegouwen GP, et al. Dynamic characteristic of gastro-oesophageal reflux in ambulatory patients with gastro-oesophageal reflux disease and normal control subjects. Scand J Gastroenterol 1995; 30: 7317.
  • 36
    Cicala M, Emerenziani S, Caviglia R, et al. Intra-oesophageal distribution and perception of acid reflux in patients with non-erosive gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2003; 18: 60513.
  • 37
    Cicala M, Gabbrielli A, Emerenziani S, et al. Effect of endoscopic augmentation of the lower oesophageal sphincter (Gatekeeper reflux repair system) on intraoesophageal dynamic characteristics of acid reflux. Gut 2005; 54: 1836.
  • 38
    Emerenziani S, Cicala M, Zhang X, et al. Measuring proximal gastroesophageal reflux: head to head comparison between multiple pH and multiple impedance. Gastroenterology 2005; 128: A1790 (abstract).
  • 39
    Bredenoord AJ, Weusten BL, Curvers WL, et al. Determinants of perception of heartburn and regurgitation. Gut 2006; 55: 3138.
  • 40
    Emerenziani S, Zhang X, Blondeau K, et al. Gastric fullness, physical activity, and proximal extent of gastroesophageal reflux. Am J Gastroenterol 2005; 100: 12516.
    Direct Link:
  • 41
    Sifrim D. Relevance of volume and proximal extent of reflux in gastro-oesophageal reflux disease. Gut 2005; 54: 1758.
  • 42
    Stein HJ, Feussner H, Kauer W, et al. Alkaline gastroesophageal reflux: assessment by ambulatory esophageal aspiration and pH monitoring. Am J Surg 1994; 167: 1638.
  • 43
    Stipa F, Stein HJ, Feussner H, et al. Assessment of non-acid esophageal reflux: comparison between long-term reflux aspiration test and fiberoptic bilirubin monitoring. Dis Esophagus 1997; 10: 248.
  • 44
    Kauer WK, Peters JH, DeMeester TR, et al. Composition and concentration of bile acid reflux into the esophagus of patients with gastroesophageal reflux disease. Surgery 1997; 122: 87481.
  • 45
    Mittal RK, Reuben A, Whitney JO, et al. Do bile acids reflux into the esophagus? A study in normal subjects and patients with gastroesophageal reflux disease. Gastroenterology 1987; 92: 3715.
  • 46
    Nehra D, Watt P, Pye JK, et al. Automated oesophageal reflux sampler – a new device used to monitor bile acid reflux in patients with gastro-oesophageal reflux disease. J Med Eng Technol 1997; 21: 19.
  • 47
    Fisher RS, Malmud LS, Roberts GS, et al. Gastroesophageal (GE) scintiscanning to detect and quantitate GE reflux. Gastroenterology 1976; 70: 3018.
  • 48
    Rhee PL, Liu J, Puckett JL, et al. Measuring esophageal distension by high-frequency intraluminal ultrasound probe. Am J Physiol Gastrointest Liver Physiol 2002; 283: G88692.
  • 49
    Tipnis NA, Liu JM, Mittal RK. Effect of acid inhibition on gastroesophageal reflux induced esophageal distension. Gastroenterology 2005; 128: A529 (abstract).
  • 50
    Pratha VS, Hogan DL, Lane JR, et al. Inhibition of pentagastrin-stimulated gastric acid secretion by pantoprazole and omeprazole in healthy adults. Dig Dis Sci. 2006; 51: 12331.
  • 51
    Barish CF, Castell DO, Richter JE. Graded esophageal balloon distention. A new provocative test for noncardiac chest pain. Dig Dis Sci 1986; 31: 12928.
  • 52
    Deschner WK, Maher KA, Cattau EL Jr, et al. Intraesophageal balloon distention vs. drug provocation in the evaluation of noncardiac chest pain. Am J Gastroenterol 1990; 85: 93843.
  • 53
    Whitehead WE, Delvaux M. Standardization of barostat procedures for testing smooth muscle tone and sensory thresholds in the gastrointestinal tract. The Working Team of Glaxo-Wellcome Research, UK. Dig Dis Sci 1997; 42: 22341.
  • 54
    Fass R, Naliboff B, Higa L, et al. Differential effect of long-term esophageal acid exposure on mechanosensitivity and chemosensitivity in humans. Gastroenterology 1998; 115: 136373.
  • 55
    Drews AM, Reddy H, Staal C et al., Sensory-motor responses to mechanical stimulation of the esophagus after sensitization with acid. World J Gastroenterol 2005; 11: 436774.
  • 56
    Janssens J, Valembois P, Hellemans J, et al. Studies on the necessity of a bolus for the progression of secondary peristalsis in the canine esophagus. Gastroenterology 1974; 67: 24551.
  • 57
    Janssens J, Valembois P, Vantrappen G, et al. Is the primary peristaltic contraction of the canine esophagus bolus-dependent? Gastroenterology 1973; 65: 7506.
  • 58
    Takeda T, Liu JM, Gui A, Kassab G, Mittal RK. Heartburn not chest pain, is the most common symptoms in response to esophageal distension in normal subjects. Gastroenterology 2001; 120: A2223.
  • 59
    Takeda T, Nabae T, Kassab G, et al. Oesophageal wall stretch: the stimulus for distension induced oesophageal sensation. Neurogastroenterol Motil 2004; 16: 7218.
  • 60
    Fass R. Sensory testing of the esophagus. J Clin Gastroenterol 2004; 38: 62841.
  • 61
    Balaban DH, Yamamoto Y, Liu J, et al. Sustained esophageal contraction: a marker of esophageal chest pain identified by intraluminal ultrasonography. Gastroenterology 1999; 116: 2937.
  • 62
    Pehlivanov N, Liu J, Mittal RK. Sustained esophageal contraction: a motor correlate of heartburn symptom. Am J Physiol Gastrointest Liver Physiol 2001; 281: G74351.
  • 63
    Bhalla V, Liu J, Puckett JL, et al. Symptom hypersensitivity to acid infusion is associated with hypersensitivity of esophageal contractility. Am J Physiol Gastrointest Liver Physiol 2004; 287: G6571.
  • 64
    Gregersen H. Biomechanics of the Gastrointestinal Tract. London: Springer Verlag, 2002.
  • 65
    Drewes AM, Reddy H, Pedersen J, et al. Multimodal pain stimulations in patients with grade B oesophagitis. Gut 2006; 55: 92632.
  • 66
    Drewes AM, Schipper KP, Dimcevski G, et al. Multimodal assessment of pain in the esophagus: a new experimental model. Am J Physiol Gastrointest Liver Physiol 2002; 283: G95103.
  • 67
    Pedersen J, Reddy H, Funch-Jensen P, et al. Differences between male and female responses to painful thermal and mechanical stimulation of the human esophagus. Dig Dis Sci 2004; 49: 106574.
  • 68
    Tutuian R, Mainie I, Agrawal A, et al. Nonacid reflux in patients with chronic cough on acid-suppressive therapy. Chest 2006; 130: 38691.
  • 69
    Mainie I, Tutuian R, Agrawal A, et al. Combined multichannel impedance-pH identifies patients with persistent reflux symptoms on acid suppression therapy who benefit from laparoscopic Nissen fundoplication. Br J Surg 2006; 93: 14837.
  • 70
    Zhang X, Tack J, Janssens J, et al. Acid and non-acid gastroesophageal reflux after endoscopic gastroplication. Evaluation of the antireflux barrier function with 24hs-pH-impedance. Gastroenterology 2003; 124: A97 (abstract).
  • 71
    Zhang Q, Lehmann A, Rigda R, et al. Control of transient lower oesophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in patients with gastro-oesophageal reflux disease. Gut 2002; 50: 1924.
  • 72
    Lidums I, Lehmann A, Checklin H, et al. Control of transient lower esophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in normal subjects. Gastroenterology 2000; 118: 713.
  • 73
    Ciccaglione AF, Marzio L. Effect of acute and chronic administration of the GABA B agonist baclofen on 24 h pH metry and symptoms in control subjects and in patients with gastro-oesophageal reflux disease. Gut 2003; 52: 46470.
  • 74
    Vela MF, Tutuian R, Katz PO, et al. Baclofen decreases acid and non-acid post-prandial gastro-oesophageal reflux measured by combined multichannel intraluminal impedance and pH. Aliment Pharmacol Ther 2003; 17: 24351.
  • 75
    Sifrim D, Tack J, Arts J, et al. Baclofen reduces weakly acidic reflux in ambulant patients with GERD. Gastroenterology 2005; 128: A531 (abstract).
  • 76
    Koek GH, Sifrim D, Lerut T, et al. Effect of the GABA(B) agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors. Gut 2003; 52: 1397402.